Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine dose study for morphine tolerance in cancer pain
ChiCTR1900027426Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morphine in cancer pain (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Increased dose of morphine. Started Nov 2019; status: recruiting.
02
Drugs
morphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR1900027426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027426.